期刊文献+

结直肠癌肝转移超声引导下经皮微波消融与手术切除疗效的对比分析 被引量:10

Comparative study of ultrasound-guided percutaneous microwave ablation and surgical resection for colorectal cancer with liver metastasis
原文传递
导出
摘要 目的比较超声引导下经皮微波消融和手术切除治疗结直肠癌肝转移的临床疗效。方法回顾性分析2012年1月至2017年6月华中科技大学同济医学院附属同济医院结直肠癌肝转移患者184例,肝转移灶选择超声引导下经皮微波消融或手术切除治疗,根据肝转移灶的治疗方式进行亚组分析,其中单纯微波组98例[男56例、女42例,年龄(59±11)岁],单纯手术组86例[男56例、女30例,年龄(56±11)岁],对两组病例基线资料进行比较,单纯微波组的转移灶病灶大小<单纯手术组,余数据差异均无统计学意义。分别分析两组患者的生存时间。根据转移灶大小,将转移灶分为直径<3 cm组和≥3 cm组,分别分析病灶直径<3 cm和≥3 cm中单纯微波组与单纯手术组患者的生存时间。根据不同结直肠癌原发灶等级分析单纯微波组与单纯手术组患者的生存时间。结果单纯微波消融组的1、3、5年总体生存率分别为100%、50.9%、20.9%;单纯手术组的1、3、5年总体生存率分别为100%、42.8%、20.8%,两组总体生存率差异无统计学意义(P=0.972)。转移灶直径≥3 cm,单纯微波消融组的1、3、5年总体生存率为100%、65.4%、12.1%;单纯手术组的1、3、5年总体生存率为100%、59.5%、30.9%,两组总体生存率差异无统计学意义(P=0.067)。单纯手术组长期生存率>单纯微波组(P=0.018)。转移灶直径<3 cm,单纯手术组与单纯微波组总体生存率差异无统计学意义(P=0.103)。在结直肠癌原发灶Duck B、C期肝转移灶治疗中,单纯微波与单纯手术治疗总体生存率差异无统计学意义(P值分别为0.376和0.385)。多因素分析显示结直肠癌转移灶大小是影响结直肠癌肝转移患者预后的独立危险因素。结论超声引导下经皮微波消融对结直肠癌肝转移灶效果好,且与手术治疗有着相似的生存预后。但对于直径≥3 cm结直肠癌肝转移灶,手术治疗远期效果优于超声引导下经皮微波消融。 Objective To study the clinical efficacy of ultrasound-guided percutaneous microwave ablation and surgical resection for liver metastases from colorectal cancer.Methods Retrospective analysis of 184 patients with liver metastases from colorectal cancer in Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology from January 2012 to June 2017.Percutaneous microwave ablation or surgical resection for liver metastases were selected under ultrasound guidance.Subgroup analysis was performed according to the treatment of liver metastases.There were 98 patients in the microwave-only group(56 males and 42 females,aged(59±11)years)and 86 cases in the surgery-only group(56 males and 30 females,aged(56±11)years).The baseline data of the two groups were compared,and the results showed that the size of the metastatic lesions in the microwave-only group was smaller than that in the surgery-only group,and the remaining data didn′t had statistical differences.The survival time of the two groups of patients was analyzed separately.According to the size of the metastases,the metastases were divided into groups with a diameter of<3 cm and a group of≥3 cm.The survival time of patients in the microwave-only group and the surgery-only group were analyzed respectively.According to the different primary tumor grades of colorectal cancer,the survival time of patients in the simple microwave-only group and the surgery-only group in the primary tumors Duck A,Duck B,and Duck C were analyzed.Results In the microwave-only group,the overall survival rates at 1,3,and 5 years were 100%,50.9%,and 20.9%;in the surgery-only group,the overall survival rates at 1,3,and 5 years were 100%,42.8%,and 20.8%,respectively.There was no significant difference in overall survival between the groups(P=0.972).Metastatic focus diameter≥3 cm:the overall survival rates of 1,3,and 5 years with microwave-only were 100%,65.4%,and 12.1%;the overall survival rates of 1,3,and 5 years with surgery-only were 100%,59.5%,and 30.9%.There was no significant difference in overall survival between the groups(P=0.067).The long-term survival rate of the surgery-only group was greater than that of the microwave-only group(P=0.018).Metastasis diameter<3 cm:there was no significant difference in overall survival between the surgery-only group and the microwave-only group(P=0.103).In the treatment of Duck B and C liver metastases of primary colorectal cancer,there was no significant difference in overall survival between microwave alone and surgery alone(P=0.376,P=0.385).Multivariate analysis showed that the size of colorectal cancer metastases was an independent risk factor affecting the prognosis of patients with colorectal cancer liver metastases.Conclusions Percutaneous microwave ablation has a good effect on colorectal cancer liver metastases and has a similar survival prognosis as surgery.For livers with color≥3 cm in colorectal cancer,the long-term survival rate of the surgery-only group is greater than that of the microwave-only group.
作者 黄哲 李开艳 周萍萍 吴晓贝 李姗姗 Huang Zhe;Li Kaiyan;Zhou Pingping;Wu Xiaobei;Li Shanshan(Department of Ultrasound,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第9期696-701,共6页 National Medical Journal of China
关键词 微波 消融技术 结直肠肿瘤 肿瘤转移 无病生存 Microwaves Ablation techniques Colorectal neoplasms Neoplasm metastasis Disease-free survival
  • 相关文献

参考文献4

二级参考文献118

  • 1Jeffrey,A.Meyerhardt,M.P.H,Robert,J.Mayer,杨昌山.结直肠癌的系统治疗[J].中国处方药,2005(10):23-25. 被引量:3
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent advancesin radiofrequency ablation for the management of hepatocellularcarcinoma. Hepat Mon 2012; 12: e5945 [PMID: 23162600 DOI:10.5812/hepatmon.5945].
  • 4Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI:10.3322/canjclin.55.2.74].
  • 5Yang JD, Roberts LR. Epidemiology and management ofhepatocellular carcinoma. Infect Dis Clin North Am 2010; 24:899-919, viii [PMID: 20937457 DOI: 10.1016/j.idc.2010.07.004].
  • 6Altekruse SF, McGlynn KA, Reichman ME. Hepatocellularcarcinoma incidence, mortality, and survival trends in the UnitedStates from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491[PMID: 19224838 DOI: 10.1200/JCO.2008.20.7753].
  • 7Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M. Imaging and Imaging-GuidedInterventions in the Diagnosis and Management of HepatocellularCarcinoma (HCC)-Review of Evidence. Iran J Radiol 2012; 9:167-177 [PMID: 23407596 DOI: 10.5812/iranjradiol.8242].
  • 8Blum HE. Hepatocellular carcinoma: HCC. Hepat Mon 2011; 11:69-70 [PMID: 22087121].
  • 9Yu SC, Yeung DT, So NM. Imaging features of hepatocellularcarcinoma. Clin Radiol 2004; 59: 145-156 [PMID: 14746783 DOI:10.1016/S0009-9260(03)00316-7].
  • 10Lee KH, O'Malley ME, Kachura JR, Haider M, Hanbidge A.Pictorial essay. Hepatocellular carcinoma: imaging and imagingguidedintervention. AJR Am J Roentgenol 2003; 180: 1015-1022[PMID: 12646447 DOI: 10.2214/ajr.180.4.1801015].

共引文献80

同被引文献114

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部